Nitrofurantoin is an antibiotic indicated for first choice treatment of acute uncomplicated lower urinary tract infections in general practice [2]. Further indications are short-term preventive treatment in urological interventions and long term treatment of complicated urinary tract infections

  • Published 2012


In 2007 the Netherlands Pharmacovigilance Centre Lareb sent an signal to the Medicines Evaluation Board (MEB) concerning four reports of cutaneous vasculitis associated with nitrofurantoin [1]. These reports were received by Lareb in the period from September 1997 to October 2006. Since then, Lareb received three additional reports of vasculitis associated… (More)


3 Figures and Tables